2015 American Transplant Congress
The Use of Bortezomib for Desensitization in ABO Incompatible and Positive Crossmatch Kidney Transplant
Introduction:ABO incompatible (ABOi) and positive crossmatch (PXM) living donor kidney transplantation is a life-saving alternative to dialysis. A variety of protocols exist utilizing plasmapheresis (PP)…2015 American Transplant Congress
Post-Transplantation Immunoadsorption Can Be Safely Withheld After ABO-Incompatible Kidney Transplantation
Background: After ABO-incompatible kidney transplantation, postoperative plasma exchange (PE) or immunoadsorption (IA) is performed per protocol or depending on postoperative A/B-titers to prevent acute rejection.…2015 American Transplant Congress
Desensitization Before Living Donor Kidney Transplantation in Highly Sensitized Patients
Renal transplantation in highly sensitized patients represents a major clinical challenge leading to long periods in the waiting list. When a living donor is available,…2015 American Transplant Congress
Pre-Transplant Desensitization Protocol and Cancer Risk in Kidney Transplantation
Introduction: Desensitization (DS) in kidney transplant is a current therapy for all cause of incompatible living donor kidney transplants (LDKT). The impact in cancer risk…2015 American Transplant Congress
Deceased Donor HLA Antibody Incompatible Renal Transplantation Without Antibody Removal: High Incidence of Acute Rejection Reduced By T-Cell Depleting Induction Therapy
Aims: Screening for HLA-specific antibodies (Ab) is routine for patients on kidney transplant waiting lists, and HLA antigens to which a patient has detectable Ab…2015 American Transplant Congress
Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers
Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…2015 American Transplant Congress
MELD as a Predictor of Post-Transplant Survival
Department of Surgery, Johns Hopkins, Baltimore.
MELD is a reliable tool to predict liver waitlist mortality. Previous studies of MELD and post-transplant outcomes have had conflicting results.METHODS: We used generalized gamma…2015 American Transplant Congress
Utilizing CDC High Risk Donors to Improve Outcomes in Liver Transplantation
General Surgery, Division of Transplant Surgery, Rush University Medical Center, Chicago, IL.
Introduction: An under-utilized demographic in liver transplantation is the CDC high-risk donor (HRD). These individuals, considered at higher risk of blood-borne diseases, contribute approximately 9%…2015 American Transplant Congress
Grip Strength, Gait Speed, and Chair Stands Predict Sarcopenia in Male But Not Female Liver Transplant Candidates
University of California, San Francisco, San Francisco, CA.
Background: Sarcopenia, as determined by cross-sectional skeletal muscle index (SMI), is associated with waitlist mortality in liver transplant (LT) candidates, but has limited clinical utility…2015 American Transplant Congress
The Impact of CDC High Risk Donors on Patient and Graft Survival After Liver Transplantation
We hypothesized that CDC high risk donors (HRD) might be younger than non-HRD and have other characteristics associated with favorable outcomes after liver transplant (LT).…
American Transplant Congress abstracts